Estrid Høgdall

23.7k total citations
325 papers, 7.3k citations indexed

About

Estrid Høgdall is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Estrid Høgdall has authored 325 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Oncology, 103 papers in Molecular Biology and 103 papers in Reproductive Medicine. Recurrent topics in Estrid Høgdall's work include Ovarian cancer diagnosis and treatment (100 papers), Endometrial and Cervical Cancer Treatments (38 papers) and Cancer-related molecular mechanisms research (35 papers). Estrid Høgdall is often cited by papers focused on Ovarian cancer diagnosis and treatment (100 papers), Endometrial and Cervical Cancer Treatments (38 papers) and Cancer-related molecular mechanisms research (35 papers). Estrid Høgdall collaborates with scholars based in Denmark, United States and United Kingdom. Estrid Høgdall's co-authors include Claus Høgdall, Susanne K. Kjær, Lise Christensen, Jan Blaakær, Ib Jarle Christensen, Lotte Nedergaard, Jens Vuust, Simon A. Gayther, Lene Lundvall and Julia S. Johansen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Estrid Høgdall

309 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estrid Høgdall Denmark	48	2.4k	2.2k	2.1k	1.6k	1.4k	325	7.3k
Masaki Mandai Japan	49	2.9k 1.2×	2.8k 1.3×	4.6k 2.2×	1.2k 0.8×	976 0.7×	354	10.7k
Wen‐Fang Cheng Taiwan	50	3.2k 1.3×	1.2k 0.5×	1.7k 0.8×	1.6k 1.0×	892 0.6×	291	8.1k
Janet S. Rader United States	52	3.1k 1.3×	1.8k 0.8×	1.8k 0.9×	2.3k 1.4×	1.4k 1.0×	210	8.4k
Alessandro D. Santin United States	53	3.2k 1.3×	2.0k 0.9×	4.6k 2.3×	1.4k 0.8×	796 0.6×	353	10.6k
Sharon P. Wilczynski United States	45	2.0k 0.8×	947 0.4×	1.9k 0.9×	888 0.5×	1.5k 1.0×	127	6.3k
Iain A. McNeish United Kingdom	41	2.9k 1.2×	1.3k 0.6×	2.9k 1.4×	940 0.6×	540 0.4×	199	6.9k
Joachim Diebold Germany	46	3.2k 1.3×	807 0.4×	2.9k 1.4×	2.0k 1.3×	1.0k 0.7×	224	8.1k
Sepp Leodolter Austria	38	1.5k 0.6×	870 0.4×	1.2k 0.6×	724 0.4×	1.2k 0.8×	181	5.5k
Pei Hui United States	36	1.0k 0.4×	802 0.4×	1.1k 0.6×	497 0.3×	584 0.4×	193	4.4k
Jerome L. Belinson United States	46	1.3k 0.6×	1.7k 0.7×	2.0k 1.0×	335 0.2×	1.8k 1.3×	229	7.2k

Countries citing papers authored by Estrid Høgdall

Since Specialization

Citations

This map shows the geographic impact of Estrid Høgdall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estrid Høgdall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estrid Høgdall more than expected).

Fields of papers citing papers by Estrid Høgdall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estrid Høgdall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estrid Høgdall. The network helps show where Estrid Høgdall may publish in the future.

Co-authorship network of co-authors of Estrid Høgdall

This figure shows the co-authorship network connecting the top 25 collaborators of Estrid Høgdall. A scholar is included among the top collaborators of Estrid Høgdall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estrid Høgdall. Estrid Høgdall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schroll, Jeppe Bennekou, et al.. (2025). Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade 2+ from childhood vaccinated women: The Trial23 cohort study. Vaccine. 73. 128142–128142.

Jochumsen, Kirsten, et al.. (2025). Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers. American Journal of Obstetrics and Gynecology. 233(2). 106.e1–106.e15.

Napolitano, George, Jeppe Bennekou Schroll, Berit Andersen, et al.. (2025). Human papillomavirus prevalence in first, second and third cervical cell samples from women HPV-vaccinated as girls, Denmark, 2017 to 2024: data from the Trial23 cohort study. Eurosurveillance. 30(27). 3 indexed citations

León‐Castillo, Alicia, Nanda Horeweg, Elke E.M. Peters, et al.. (2025). Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer. Gynecologic Oncology. 197. 43–50. 1 indexed citations

Hjortebjerg, Rikke, et al.. (2024). The IGF–PAPP-A–Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer. International Journal of Molecular Sciences. 25(4). 2014–2014. 2 indexed citations

Høgdall, Estrid, Bente Glintborg, Sisse Rye Ostrowski, et al.. (2024). Neoehrlichia mikurensis is uncommon in rheumatological patients receiving tumour necrosis factor inhibitors and in blood donors: a retrospective cohort study. RMD Open. 10(1). e003660–e003660. 1 indexed citations

Høgdall, Estrid, et al.. (2024). Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy Resistance. Anticancer Research. 45(1). 11–26. 3 indexed citations

Johansen, Julia S., Finn Ole Larsen, Susann Theile, et al.. (2024). Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical Cancer Research. 30(16). 3428–3437. 3 indexed citations

Kovacevic, Bojan, Peter Vilmann, Linea Cecilie Melchior, et al.. (2023). Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Cancers. 15(14). 3677–3677. 6 indexed citations

10.

Oliveira, Douglas V.N.P., et al.. (2023). Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer. PLoS ONE. 18(5). e0282576–e0282576. 2 indexed citations

11.

Jensen, Steffen Grann, Alice Riva, Alessia Paganotti, et al.. (2021). A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies. PLoS ONE. 16(6). e0253687–e0253687. 6 indexed citations

12.

Oliveira, Douglas V.N.P., et al.. (2021). Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer. PLoS ONE. 16(7). e0255142–e0255142. 8 indexed citations

13.

Pedersen, Mette Ølgod, Anupama Reddy, Cassandra Love, et al.. (2019). PD‐L1 expression is low in large B‐cell lymphoma with MYC or double‐hit translocation. Hematological Oncology. 37(4). 375–382. 7 indexed citations

14.

Bager, Cecilie L., Nicholas Willumsen, S.N. Kehlet, et al.. (2016). Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study. Cancer Epidemiology Biomarkers & Prevention. 25(9). 1348–1355. 12 indexed citations

15.

Faber, Mette Tuxen, Allan Jensen, Estrid Høgdall, et al.. (2012). Use of dairy products, lactose, and calcium and risk of ovarian cancer – Results from a Danish case-control study. Acta Oncologica. 51(4). 454–464. 19 indexed citations

16.

Høgdall, Estrid, Lise Christensen, Susanne K. Kjær, et al.. (2010). Limited prognostic value of tissue protein expression levels of BCl‐2 in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study. Apmis. 118(8). 557–564. 2 indexed citations

17.

Dafou, Dimitra, Susan J. Ramus, Aleksandra Gentry‐Maharaj, et al.. (2009). Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival (vol 18, pg 1869, 2009). UCL Discovery (University College London). 1 indexed citations

18.

Kjær, Susanne K., Eva Wozniak, Estrid Høgdall, et al.. (2008). BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark. Clinical Cancer Research. 14(12). 3761–3767. 79 indexed citations

19.

Høgdall, Estrid, Julia S. Johansen, Morten Buus Jørgensen, et al.. (2003). Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstetricia Et Gynecologica Scandinavica. 82(3). 287–293. 69 indexed citations

20.

Petersen, Bodil Laub, Estrid Høgdall, & Niels Kryger‐Baggesen. (1999). Case Reports. Acta Obstetricia Et Gynecologica Scandinavica. 78(9). 826–830. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact